However, yeast infections have been mentioned by some users
For tirzepatide, those are GLP-1 and GIP
Summary Semaglutide therapy, although FDA-approved and recommended in obese and/or diabetic patients and is subjected to adverse effects in certain individuals
Jan 10 2022;80(2):306-316
Heart, kidney, brain, sleep, metabolism, inflammation
Stop and Seek Help If Persistent severe headaches that do not resolve with dose reduction Significant mood instability or personality changes Any suspicious lumps, unexplained weight loss, or other potential cancer symptoms Completion of planned cycle duration (4-6 weeks recommended maximum) Adverse interaction with other medications or supplements Dihexa is a research compound with no FDA approval and limited human safety data